Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older

The most‐used prognostic scheme for malignant gliomas included only patients aged 18 to 70 years. The purpose of this study was to develop a prognostic model for patients ≥70 years of age with newly diagnosed glioblastoma.

[1]  Jacob G. Scott,et al.  Effectiveness of radiotherapy for elderly patients with glioblastoma. , 2011, International journal of radiation oncology, biology, physics.

[2]  Samuel T Chao,et al.  Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. , 2011, Neuro-oncology.

[3]  J. Flickinger,et al.  Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era , 2010, Journal of Neuro-Oncology.

[4]  H. Duffau,et al.  Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. , 2010, Neuro-oncology.

[5]  P. Kleihues,et al.  IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas , 2009, Clinical Cancer Research.

[6]  A. Reiner,et al.  Glioblastoma in the elderly , 2009, Cancer.

[7]  Katherine S Panageas,et al.  Patterns of care in elderly glioblastoma patients , 2008, Annals of neurology.

[8]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[9]  M. Berger,et al.  GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME , 2008, Neurosurgery.

[10]  A. Sloan,et al.  Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. , 2008, Journal of neurosurgery.

[11]  Luc Taillandier,et al.  Radiotherapy for glioblastoma in the elderly. , 2007, The New England journal of medicine.

[12]  J. Delattre,et al.  Glioma in the elderly , 2006, Current opinion in oncology.

[13]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[14]  Susan M. Chang,et al.  Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. , 2004, Neuro-oncology.

[15]  D. Louis,et al.  Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma , 2004, Clinical Cancer Research.

[16]  J. Jääskeläinen,et al.  Debulking or biopsy of malignant glioma in elderly people – a randomised study , 2003, Acta Neurochirurgica.

[17]  M. Berger,et al.  Epidemiology of primary brain tumors: current concepts and review of the literature. , 2002, Neuro-oncology.

[18]  F. Davis,et al.  Epidemiology of brain tumors. , 2000, Current opinion in neurology.

[19]  S. Fedder.  The limited value of cytoreductive surgery in elderly patients with malignant gliomas. , 1994, Neurosurgery.

[20]  D. Nelson,et al.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.

[21]  J F Lawless,et al.  Regression and recursive partition strategies in the analysis of medical survival data. , 1988, Journal of clinical epidemiology.